Table 5 Gene-specific rates of tumor detection using imaging screening for the total cohort.

From: Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma–pheochromocytoma syndrome

 

Subjects with true positive screens (excluding recurrence) (n)

Total subjects (n)

Percent positive subjects

SDHA

1

9

11%

SDHB

29

188

15%

SDHC

1

28

4%

SDHD

14

35

40%

SDHAF2

0

3

0.00%

Total

45

263

17%

  1. True positive means tumor was SDHx-related including paragangliomas (PGL)/pheochromocytomas (PCC), renal cell carcinoma (RCC), or gastrointestinal stromal tumors (GIST).
Back to article page